BioCentury
ARTICLE | Company News

Myriad, BeiGene deal

April 13, 2017 11:13 PM UTC

BeiGene and Myriad Genetics will develop a companion diagnostic to support development of BeiGene's BGB-290 using Myriad's myChoice Homologous Recombination Deficiency (HRD) and BRACAnalysis CDx tests...